Monograph
A01AB04 - Amphotericin B |
Not porphyrinogenic |
NP |
Rationale
Not significantly absorbed. Not metabolised.
Chemical description
Lozenges for local oral use in oral candidiasis and other oral infections. About 10 % of the lozenge is absorbed, corresponding to about 4 mg systemic exposure. Probably not metabolised but stored in the body for prolonged periods.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
United Kingdom
Norway
Finland© NAPOS 2024